There’s quite a debate in the CPG world about the investment in digital marketing. While some are increasing their digital budgets, does a pancake syrup company need to spend much money? However, with pharma brands, online is essential to a successful marketing strategy.
According to the National Institutes of Health, people with a mental health diagnosis committed less than 5 percent of gun-related homicides between 2001 and 2010. Mental health experts, including representatives from the American Psychological Association, have called it “unfounded” to blame mass shootings on mental illness in place of considering other possible factors, such as hate, bigotry, and access to assault weapons.
Gun violence isn’t just a criminal justice issue; it’s a public health issue. There was nearly a 30 percent increase in homicides between 2019 and 2020, making it the most significant one-year increase in six decades. The number of gun deaths in 2021 climbed even higher and is approaching the previous peaks in gun death rates in the early 1970s and early 1990s.
Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. To make matters worse, a former executive at Cerebral, a well-funded online mental health startup, claims in a labor lawsuit that the company fired him after he complained that the company was too quick to prescribe powerful stimulant drugs. Do online mental health apps work?
President Joe Biden last week ordered flags flown at half-staff at the White House and all public buildings and grounds until sunset Monday, imploring Americans to “not grow numb to the sorrow.” or 1 million deaths from Covid. This didn’t have to happen and those responsible need to be held accountable.
- Just 13% of people trust the pharma companies they interact with.
- 68% say the interactions feel transactional.
- Only a third agree that organizations know their communication preferences.
If You’re Short On Time:
- The U.S. Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes.
- The drug led to impressive blood sugar and body weight drops in clinical trials.
- The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes.
- Will patients, who are obese and don’t have Type 2 diabetes, ask for the drug for weight loss, and will patients understand the risks?
Short on Time?
- Adalytics reported that for nine months, billions of ad auctions for space on Gannett’s USA Today website resulted in brands unknowingly getting stuck with their ads running on other Gannett sites — often remote community sites.
- Ads from who-knows-how-many companies ran in the wrong places for nine months.
- Not a single brand noticed this, and not a single media buyer noticed the fraud.
- Online ad fraud is costing pharma millions